Key TakeawaysPsychiatric disorders affect over 20% of US adults, presenting complex challenges in diagnosis and treatment due to frequent comorbidities.Despite past challenges, recent advancements in brain biology and precision psychiatry offer new opportunities for innovative treatments.Biopharma companies are exploring novel drug targets, mechanisms of action, and biomarkers to enhance patient care and address unmet needs.Strategic […]
